Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-04

Clinical Trial Update: Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating tapinarof for atopic dermatitis in children and adults has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tapinarof (tapinarof)

Snippet

Sponsor: Organon and Co | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2025-09-04